EPO under fire for its approach to ST.26 sequence listings
The IPKat
AUGUST 1, 2022
There is an international requirement for the DNA, RNA and protein sequences disclosed in a patent application to be provided in a sequence listing. Sequence listings are used by patent offices to search the prior art for the listed sequences. 26 sequence listings has the aim of increasing public access to patent sequences.
Let's personalize your content